Mirae Asset Global Investments’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $64.6K | Buy |
4,605
+595
| +15% | +$8.34K | ﹤0.01% | 1223 |
|
|
2025
Q1 | $63.1K | Buy |
4,010
+110
| +3% | +$1.73K | ﹤0.01% | 1199 |
|
|
2024
Q4 | $55.8K | Sell |
3,900
-328
| -8% | -$4.69K | ﹤0.01% | 1254 |
|
|
2024
Q3 | $39.6K | Buy |
4,228
+772
| +22% | +$7.23K | ﹤0.01% | 1340 |
|
|
2024
Q2 | $32.6K | Sell |
3,456
-43,198
| -93% | -$407K | ﹤0.01% | 1318 |
|
|
2024
Q1 | $469K | Buy |
+46,654
| New | +$469K | ﹤0.01% | 1932 |
|
|
2023
Q4 | – | Sell |
-38,023
| Closed | -$202K | – | 2529 |
|
|
2023
Q3 | $202K | Buy |
38,023
+606
| +2% | +$3.22K | ﹤0.01% | 2292 |
|
|
2023
Q2 | $336K | Buy |
37,417
+5,435
| +17% | +$48.8K | ﹤0.01% | 2130 |
|
|
2023
Q1 | $352K | Buy |
31,982
+11,509
| +56% | +$127K | ﹤0.01% | 2090 |
|
|
2022
Q4 | $303K | Buy |
20,473
+4,361
| +27% | +$64.5K | ﹤0.01% | 2156 |
|
|
2022
Q3 | $308K | Buy |
+16,112
| New | +$308K | ﹤0.01% | 2143 |
|